Skip to main content
CLNN
NASDAQ Life Sciences

Clene Swings to $3.92M Third-Quarter Net Income

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.77
Mkt Cap
$53.587M
52W Low
$3.015
52W High
$13.5
52W Position info
25% above low
Off High info
72% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

CLNN sits 25% above its 52-week low of $3.015.

Summary

Clene reported third-quarter net income of $3.92 million, or 5 cents a share, on revenue of $56,000, a sharp reversal from the $13.4 million net loss it posted for Q2 2026, with the profit driven by warrant liability gains. The swing matters for a micro-cap that carried a going concern warning in its Q2 10-Q and has been funding itself through small registered direct offerings, including a $4 million raise at $3.28 a share in September. A profitable quarter, if it holds, eases the immediate cash pressure, though the company's cash runway extends only to mid-Q1 2027. The NDA for CNM-Au8 seeking accelerated approval was submitted to the FDA on October 19, and that review decision is the real driver from here, while Clene plans to initiate the Phase 3 RESTORE-ALS confirmatory trial of CNM-Au8 in ALS in 2Q of 2027.

At the time of this announcement, CLNN was trading at $3.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53.6M. The 52-week trading range was $3.02 to $13.50. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CLNN - Latest Insights

CLNN
Nov 04, 2026, 8:36 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.77
Real-time Price: $3.52 info
Change: -$0.250 (-7%) info
Market Cap: $49.832M info
CLNN
Oct 19, 2026, 8:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $3.16
Real-time Price: $3.52 info
Change: +$0.360 (+11%) info
Market Cap: $49.832M info
CLNN
Sep 16, 2026, 1:05 PM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $4.09
Real-time Price: $3.52 info
Change: -$0.570 (-14%) info
Market Cap: $49.832M info
CLNN
Sep 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.09
Real-time Price: $3.52 info
Change: +$0.430 (+14%) info
Market Cap: $49.832M info
CLNN
Aug 14, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.13
Real-time Price: $3.52 info
Change: -$0.610 (-15%) info
Market Cap: $49.832M info